# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-11-018892
Filing Date
2011-03-31
Accepted
2011-03-31 14:41:07
Documents
12
Period of Report
2011-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | v216857_6k.htm | 6-K | 4691808
2 | GRAPHIC | a-logo.jpg | GRAPHIC | 5341
3 | GRAPHIC | c2-logo.jpg | GRAPHIC | 6108
4 | GRAPHIC | c2-pg01.jpg | GRAPHIC | 160531
5 | GRAPHIC | c2-pg10.jpg | GRAPHIC | 43959
6 | GRAPHIC | c2-pg24.jpg | GRAPHIC | 38733
7 | GRAPHIC | c2-pg30.jpg | GRAPHIC | 24925
8 | GRAPHIC | c2-pg33a.jpg | GRAPHIC | 44839
9 | GRAPHIC | c2-pg33b.jpg | GRAPHIC | 39213
10 | GRAPHIC | c2-pg34.jpg | GRAPHIC | 47866
11 | GRAPHIC | chart.jpg | GRAPHIC | 41345
12 | GRAPHIC | sixk-logo.jpg | GRAPHIC | 8835
| Complete submission text file | 0001144204-11-018892.txt |  | 5330450

Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 11725431
SIC: 2834 Pharmaceutical Preparations